A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 58,975 shares of EXAS stock, worth $3.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
58,975
Previous 66,484 11.29%
Holding current value
$3.39 Million
Previous $2.16 Million 35.14%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $227,898 - $399,103
-7,509 Reduced 11.29%
58,975 $2.92 Million
Q3 2022

Nov 07, 2022

SELL
$31.97 - $49.37 $314,456 - $485,603
-9,836 Reduced 12.89%
66,484 $2.16 Million
Q2 2022

Aug 09, 2022

SELL
$35.61 - $76.23 $169,895 - $363,693
-4,771 Reduced 5.88%
76,320 $3.01 Million
Q1 2022

May 13, 2022

SELL
$57.56 - $82.54 $1.35 Million - $1.93 Million
-23,428 Reduced 22.42%
81,091 $5.67 Million
Q4 2021

Feb 11, 2022

BUY
$72.5 - $100.68 $922,490 - $1.28 Million
12,724 Added 13.86%
104,519 $8.14 Million
Q3 2021

Nov 09, 2021

SELL
$90.24 - $124.05 $638,718 - $878,025
-7,078 Reduced 7.16%
91,795 $8.76 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $1.05 Million - $1.56 Million
-11,174 Reduced 10.15%
98,873 $12.3 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $5.8 Million - $7.71 Million
-49,723 Reduced 31.12%
110,047 $14.5 Million
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $3.5 Million - $4.99 Million
-35,131 Reduced 18.03%
159,770 $21.2 Million
Q3 2020

Nov 09, 2020

SELL
$72.92 - $102.01 $2.9 Million - $4.05 Million
-39,708 Reduced 16.93%
194,901 $19.9 Million
Q2 2020

Aug 10, 2020

SELL
$55.75 - $92.75 $1.66 Million - $2.77 Million
-29,857 Reduced 11.29%
234,609 $20.4 Million
Q1 2020

May 14, 2020

BUY
$37.9 - $104.44 $10 Million - $27.6 Million
264,466 New
264,466 $15.3 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.